financetom
Business
financetom
/
Business
/
Industrial automation firm Reko's FY 2025 gross profit up 66.8%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Industrial automation firm Reko's FY 2025 gross profit up 66.8%
Oct 9, 2025 11:27 AM

Overview

* Canada's Reko ( RKIGF ) fiscal 2025 sales declined 4.8% yr/yr due to lower volumes and tariff-related delays

* Gross profit for fiscal 2025 rose 66.8% yr/yr, driven by customer mix

* Adjusted EPS for fiscal 2025 was C$0.39, compared to a loss of C$0.13 last year

Outlook

* Company did not provide specific guidance for future quarters or full year

Result Drivers

* PROJECT MIX - Improved gross profit driven by a favorable project mix and focus on non-automotive customers

* DEFERRED TAX ASSETS - Net income benefited from re-recognition of deferred tax assets

* DISCIPLINED EXECUTION - Co attributes results improvement to disciplined execution and diversification focus

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

FY Sales C$42.15

mln

FY EPS C$0.19

FY Basic C$0.19

EPS

FY Gross C$7.20

Profit mln

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Oct 6, 2025
By Rishika Sadam Oct 6 (Reuters) - Eli Lilly ( LLY ) will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's...
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
Oct 6, 2025
Oct 6 (Reuters) - AstraZeneca ( AZN ) said on Monday its precision drug Datroway improved overall survival and progression free survival in patients with an advanced form of breast cancer versus chemotherapy in a trial when given early during treatment. The treatment, which is being developed with partner Daiichi Sankyo ( DSKYF ), was given as first-line therapy in...
G2 Risk Solutions Finalizes EverC Transaction
G2 Risk Solutions Finalizes EverC Transaction
Oct 6, 2025
BURLINGAME, Calif.--(BUSINESS WIRE)-- G2 Risk Solutions (G2RS) today announced the completion of its transaction with EverC, expanding G2RS’ global reach and adding proven AI-powered risk solutions to its product suite. Now with the acquired capabilities of EverC, G2RS delivers a comprehensive suite of AI- and analyst-driven risk solutions. Products are built to help global banks, merchant acquirers and online marketplaces...
Bitcoin Depot Insider Sold Shares Worth $3,258,916, According to a Recent SEC Filing
Bitcoin Depot Insider Sold Shares Worth $3,258,916, According to a Recent SEC Filing
Oct 6, 2025
03:15 AM EDT, 10/06/2025 (MT Newswires) -- Brandon Taylor Mintz, Director, Chief Executive Officer, on October 01, 2025, sold 842,732 shares in Bitcoin Depot ( BTM ) for $3,258,916. SEC Filing: https://www.sec.gov/Archives/edgar/data/1901799/000119312525230651/xslF345X05/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved